Abstract:Tumor‐targeting bacteria have been developed as powerful anticancer agents. Salmonella typhimurium VNP20009, a representative tumor‐targeting strain, has been systemically administered as a single‐agent therapy at doses of 1 × 106 to 3 × 106 colony‐forming unit (cfu)/mouse, or in combination with other antitumor agents at doses of 1 × 104 to 2 × 105 cfu/mouse. Recently, we reported that oral delivery of VNP20009 at the dose of 1 × 109 cfu/mouse induced significant anticancer effects comparable to that induced by systemic administration of this strain at 1 × 104 cfu/mouse. To further address the efficacy and safety of oral administration of bacteria, here we performed a systemically comparative analysis of anticancer efficacy and toxicity of VNP20009 administered: (i) orally at a dose of 1 × 109 cfu/mouse (VNP9‐oral); (ii) intraperitoneally at a dose of 1 × 104 cfu/mouse (VNP4‐i.p.); or (iii) intraperitoneally at a dose of 1 × 106 cfu/mouse in tumor‐free and tumor‐bearing murine models. The results showed that VNP9‐oral, similar to VNP4‐i.p., induced significant tumor growth inhibition whereas VNP6‐i.p. induced better anticancer effect in the B16F10 melanoma model. Among three treatments, VNP9‐oral induced the mildest and reversible toxicity whereas VNP6‐i.p. resulted in the most serious and irreversible toxicities when compared to other two treatments. Moreover, the combination of VNP9‐oral with a low dose of chemotherapeutics produced comparable antitumor effects but displayed significantly reduced toxicity when compared to VNP6‐i.p. The findings demonstrated that oral administration, as a novel avenue in the application of bacteria, is highly safe and effective. Moreover, the present preclinical study should facilitate the optimization of bacterial therapies with improved anticancer efficacy and reduced adverse effects in future clinical trials. (Cancer Sci 2009; 100: 2437–2443)

Tumor-Targeting Salmonella Typhimurium Improves Cyclophosphamide Chemotherapy At Maximum Tolerated Dose And Low-Dose Metronomic Regimens In A Murine Melanoma Model

Oral Delivery of Tumor‐targeting Salmonella for Cancer Therapy in Murine Tumor Models

Enhanced Therapeutic Effect by Combination of Tumor-Targeting Salmonella and Endostatin in Murine Melanoma Model

Oral Delivery of Tumor‐targeting Salmonella Exhibits Promising Therapeutic Efficacy and Low Toxicity

Abstract 2678: Traditional Chinese Medicine (TCM) in combination withS. typhimuriumA1-R for cancer treatment

Targeted Cancer Therapy Using Engineered Salmonella typhimurium.

Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhimurium VNP20009 in anti-PD1 therapy against melanoma

Potentiating bacterial cancer therapy using hydroxychloroquine liposomes.

Optimized Attenuated Salmonella Typhimurium Suppressed Tumor Growth and Improved Survival in Mice

Toxicology and Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R Compared to VNP 20009 in a Syngeneic Mouse Tumor Model in Immunocompetent Mice

Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model

Traditional Chinese Medicine (Tcm) Enhances Efficacy And Reduces Toxicity Of Tumor-Targeting S. Typhimurium A1-R In A Syngeneic Breast Cancer Metastatic Mouse Model

Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection

Radiotherapy Combined with an Engineered Salmonella Typhimurium Inhibits Tumor Growth in a Mouse Model of Colon Cancer.

Genetically Engineered Salmonella Typhimurium: Recent Advances in Cancer Therapy.

Salmonella typhimurium A1-R tumor targeting in immunocompetent mice is enhanced by a traditional Chinese medicine herbal mixture.

Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model.

Tumor-targeting Salmonella typhimurium , a natural tool for activation of prodrug 6MePdR and their combination therapy in murine melanoma model

Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model

Modulation of Salmonella Tumor-Colonization and Intratumoral Anti-angiogenesis by Triptolide and Its Mechanism.

Triptolide Modulates Tumour-Colonisation and Anti-Tumour Effect of Attenuated Salmonella Encoding DNase I